Memo Therapeutics
Developer of antibody discovery and immune repertoire analysis platform designed to transform the lives of patients with virus infections and cancer. The company's platform creates a recombinant in vi...
Valuation
$0
Share Price
N/A
Total Raised
$96.6M
Last Round
N/A